AKT1 and cystic fibrosis: In 2011, Bhattacharyya et al. demonstrated that miR-155 may play a central role in controlling inflammation in cystic fibrosis lung epithelial cells by regulating IL-8 levels through the PI3K/AKT signaling pathway activation42.